Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REACT-AF: Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

NCT05836987 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT05836987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05836987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REACT-AF: Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Lead sponsor
Johns Hopkins University
Phase
Phase 3
Overall status
Recruiting
Start date
July 13, 2023
Completion date
July 31, 2029
Enrollment
5,350 (estimated)
Sites
93

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation